- Home
- Publications
- Publication Search
- Publication Details
Title
Dupilumab for treatment of atopic dermatitis
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 11, Issue 5, Pages 467-474
Publisher
Informa UK Limited
Online
2018-03-20
DOI
10.1080/17512433.2018.1449642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
- (2018) Andreas Wollenberg et al. Journal of Allergy and Clinical Immunology-In Practice
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
- (2016) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Atopic Dermatitis on Quality of Life
- (2015) Carlos Lifschitz ANNALS OF NUTRITION AND METABOLISM
- Dupilumab Improves Patient-Reported Outcomes (PROs) in a Phase 2 Study in Adults with Moderate-to-Severe Atopic Dermatitis
- (2015) Eric Simpson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
- (2014) Jennifer D. Hamilton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TNF-α and Th2 Cytokines Induce Atopic Dermatitis–Like Features on Epidermal Differentiation Proteins and Stratum Corneum Lipids in Human Skin Equivalents
- (2014) Mogbekeloluwa O. Danso et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2014) Robert Sidbury et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2014) Lawrence F. Eichenfield et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population–based study
- (2013) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
- (2013) Evelien Roekevisch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
- (2012) Andreas Wollenberg et al. Annals of Dermatology
- The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort
- (2012) David J. Margolis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
- (2012) J. Ring et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
- (2012) J. Ring et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis
- (2012) Lei Bao et al. MOLECULAR IMMUNOLOGY
- Management of Difficult-to-Treat Atopic Dermatitis
- (2012) Peter D. Arkwright et al. Journal of Allergy and Clinical Immunology-In Practice
- Cytokine modulation of atopic dermatitis filaggrin skin expression
- (2009) Michael D. Howell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three
- (2009) Joseph A. Odhiambo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment
- (2008) A. Wollenberg et al. ALLERGY
- Proactive therapy of atopic dermatitis - an emerging concept
- (2008) A. Wollenberg et al. ALLERGY
- Quality of life of children with atopic dermatitis and their families
- (2008) Stephen P McKenna et al. Current Opinion in Allergy and Clinical Immunology
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
- The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review
- (2008) Anthony J. Mancini et al. PEDIATRIC DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started